documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

241 rows where document_type = "Notice" and posted_year = 2001 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_month, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

agency_id 2

posted_year 1

  • 2001 · 241 ✖

document_type 1

  • Notice · 241 ✖
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
EPA-HQ-ORD-2004-0015-0002 EPA EPA-HQ-ORD-2004-0015 Project Work Plan for Revised Air Quality Criteria for Ozone and Related Photochemical Oxidants Notice Federal Register Document 2001-12-31T05:00:00Z 2001 12 2001-12-31T05:00:00Z 2002-02-16T04:59:59Z 2010-07-15T19:14:49Z 67524 0 0 09000064800c4bee
FDA-2001-N-0018-0001 FDA Preparation for ICH Meetings in Brussels, Belgium FDA-2001-N-0018 Preparation for ICH Meetings in Brussels, Belgium, Including Progress on Implementation of the Common Technical Document; Notice of Public Meeting Notice General Notice 2001-12-31T05:00:00Z 2001 12     2025-02-10T16:52:56Z 01-32123 0 0 09000064804b5107
FDA-1978-N-0018-0441 FDA Sunscreen Drug Products -OPEN FDA-1978-N-0018 Sunscreen Drug Products for Over-the-Counter Human Use; Final Monograph; Partial Stay; Final Rule Notice Notice of Stay of Action 2001-12-31T05:00:00Z 2001 12 2001-12-31T05:00:00Z 2002-04-02T04:59:59Z 2019-07-25T19:32:43Z 01-32086 0 0 090000648055a801
FDA-1993-D-0022-0001 FDA Microbiological Testing Antimicrobial Drug Residues in Foods FDA-1993-D-0022 FDA Notice NAD-Notice of Availability of Data 2001-12-31T05:00:00Z 2001 12 2001-12-27T05:00:00Z   2008-05-16T23:23:01Z   0 0 09000064804face9
FDA-2001-N-0015-0001 FDA Agency Information Collection; Customer/Partner Ser Surveys FDA-2001-N-0015 Agency Information Collection Activities; Submission for OMB Review; Comment Request; Customer/Partner Service Surveys Notice 30 Day Proposed Information Collection 2001-12-31T05:00:00Z 2001 12 2001-12-20T05:00:00Z 2002-01-23T04:59:59Z 2025-01-17T16:28:25Z 01-31335 0 0 09000064804b4d73
EPA-HQ-RCRA-2001-0052-0001 EPA EPA-HQ-RCRA-2001-0052 Proposed Collection, Comment Request, Final Authorization for Hazardous Waste Management, Information Collection Request Renewal Notice Federal Register Document 2001-12-28T05:00:00Z 2001 12     2008-01-08T21:20:08Z 67245 0 0 09000064800e39f2
FDA-2001-D-0223-0001 FDA Guidance on Labeling of Reprocessed Single Use Devices FDA-2001-D-0223 FDA Notice N-Notice 2001-12-28T05:00:00Z 2001 12 2001-12-28T05:00:00Z 2002-03-21T04:59:59Z 2008-04-25T02:28:02Z   0 0 09000064804e5374
FDA-2000-D-1403-0001 FDA Potassium Iodide as a Thyroid Blocking Agent FDA-2000-D-1403 Potassium Iodide as a Thyroid Blocking Agent in Radiation Emergencies Notice Guidance 2001-12-21T05:00:00Z 2001 12 2021-10-01T04:00:00Z 2002-12-12T04:59:59Z 2024-11-07T21:53:19Z   1 0 09000064804f0f7f
EPA-HQ-OAR-2002-0003-0085 EPA Boutique Fuels -- White Paper ("Study of Unique Gasoline Fuel Blends ("Boutique Fuels''), Effects on Fuel Supply and Distribution and Potential Improvements'') Legacy Docket ID #: A-2001-20 EPA-HQ-OAR-2002-0003 EPA Staff White Paper That Explores a Number of Options for Addressing Boutique Fuels in the Longer Term; Extension of Public Comment Period Notice Extension of Comment Period 2001-12-19T05:00:00Z 2001 12     2021-05-29T18:02:39Z 01-31244 0 0 09000064800bca27
EPA-HQ-RCRA-2002-0001-0025 EPA EPA-HQ-RCRA-2002-0001 Solicitation of Proposals and Request for Comment, May 23, 1995, Final Rule Notice Federal Register Document 2001-12-17T05:00:00Z 2001 12     2008-01-08T21:15:47Z 27282 0 0 09000064800df75b
EPA-HQ-RCRA-2002-0001-0008 EPA EPA-HQ-RCRA-2002-0001 Regulatory Reinvention (XL) Pilot Projects; Project XL Draft Final Project Agreement: Waste Management, Inc. Landfill Bioreactor Systems, Notice of Availablity of U.S. Waste of Virginia, Inc., And King George Landfills, Inc. Final Project Agreement Notice Federal Register Document 2001-12-17T05:00:00Z 2001 12     2008-01-08T21:09:07Z 54520 0 0 09000064800df6ef
EPA-HQ-RCRA-2002-0001-0022 EPA EPA-HQ-RCRA-2002-0001 Alternate Liner Performance, Leachate Recirculation, And Bioreactor Landfills: Request for Information and Data Notice Federal Register Document 2001-12-17T05:00:00Z 2001 12     2008-01-08T21:11:31Z 18014 0 0 09000064800df745
EPA-HQ-RCRA-2002-0001-0027 EPA EPA-HQ-RCRA-2002-0001 Notice of Modification to Project XL Notice Federal Register Document 2001-12-17T05:00:00Z 2001 12     2008-01-08T21:09:07Z 19872 0 0 09000064800df768
EPA-HQ-RCRA-2002-0001-0010 EPA EPA-HQ-RCRA-2002-0001 Regulatory Reinvention (XL) Pilot Projects; Notice of Availability of Final Project Agreements and Related Documents Notice Federal Register Document 2001-12-17T05:00:00Z 2001 12     2008-01-08T21:17:57Z 63250 0 0 09000064800df700
EPA-HQ-RCRA-2002-0001-0026 EPA EPA-HQ-RCRA-2002-0001 Regulatory Reinvention (XL) Pilot Projects; Solicitation of Proposals for and Request for Comment on Project XL Notice Federal Register Document 2001-12-17T05:00:00Z 2001 12     2008-01-08T21:17:57Z 47929 0 0 09000064800df764
FDA-2001-N-0172-0002 FDA Prescription Drug Product Labeling; Medication Guide Require FDA-2001-N-0172 FDA Notice N-Notice 2001-12-17T05:00:00Z 2001 12 2001-12-17T05:00:00Z 2002-01-15T04:59:59Z 2008-04-25T02:27:22Z   0 0 09000064804e0ae7
FDA-2001-N-0230-0002 FDA Prescription Drug User Fee Act (PDUFA) FDA-2001-N-0230 FDA Notice NCR-Notice of Correction 2001-12-07T05:00:00Z 2001 12     2008-04-25T02:38:50Z   0 0 09000064804e5d77
FDA-2001-D-0040-0001 FDA Food-Effect Bioavailability & Fed Bioequivalence Studies FDA-2001-D-0040 FDA Notice NAD-Notice of Availability of Data 2001-11-29T05:00:00Z 2001 11 2001-11-29T05:00:00Z 2002-01-29T04:59:59Z 2008-04-25T01:57:07Z   0 0 09000064804b6d71
EPA-HQ-RCRA-2001-0041-0001 EPA EPA-HQ-RCRA-2001-0041 Agency Information Collection Activities: Submission for OMB Review; Comment Request; Requirements for Generators, Transporters, and Hazardous Waste Management Facilities under the RCRA Hazardous Waste Manifest System, EPA ICR No. 801.14 Notice Federal Register Document 2001-11-27T05:00:00Z 2001 11 2001-11-27T05:00:00Z 2002-01-29T04:59:59Z 2008-01-08T21:20:56Z 59248 0 0 09000064800e2b7b
FDA-2001-N-0070-0002 FDA Agency Information Collection Recall Regulations FDA-2001-N-0070 Agency Information Collection Activities; Submission for OMB Review; Comment Request; FDA Recall Regulations Notice 30 Day Proposed Information Collection 2001-11-27T05:00:00Z 2001 11 2001-08-17T04:00:00Z 2001-09-18T03:59:59Z 2024-12-09T19:21:59Z 01-20842 0 0 09000064804b825f
EPA-HQ-ORD-2004-0012-0020 EPA EPA-HQ-ORD-2004-0012 Trichloroethylene Health Risk Assessment Notice Federal Register Document 2001-11-26T05:00:00Z 2001 11     2025-06-27T02:29:51Z 59018 0 0 09000064800c4aa4
FDA-2001-D-0032-0004 FDA Clinical Studies Section for Prescription Drugs & Biologics FDA-2001-D-0032 FDA Notice NEC-Notice of Extension 2001-11-21T05:00:00Z 2001 11 2001-11-21T05:00:00Z 2001-11-27T04:59:59Z 2008-04-25T01:57:06Z   0 0 09000064804b6347
FDA-2001-D-0219-0002 FDA Establishment & Operation of Clinical Trial Monitoring Comm FDA-2001-D-0219 Draft Guidance for Clinical Trial Sponsors on the Establishment and Operation of Clinical Trial Data Monitoring Committees; Availability Notice NAD-Notice of Availability of Data 2001-11-20T05:00:00Z 2001 11 2001-11-19T05:00:00Z 2002-02-20T04:59:59Z 2010-05-10T16:34:55Z   0 0 09000064804e4e02
FDA-1999-D-1301-0001 FDA Information Request & Discipline Review Letter FDA-1999-D-1301 Guidance for Industry: Information Request & Discipline Review Letters Under the Prescription Drug User Fee Act Notice Guidance 2001-11-20T05:00:00Z 2001 11 2001-11-20T05:00:00Z   2025-06-17T21:52:51Z   1 0 09000064804da900
FDA-2001-N-0230-0001 FDA Prescription Drug User Fee Act (PDUFA) FDA-2001-N-0230 FDA Notice NM-Notice of Meeting 2001-11-19T05:00:00Z 2001 11 2001-11-19T05:00:00Z 2002-01-26T04:59:59Z 2008-04-25T02:38:50Z   0 0 09000064804e5c39
FDA-1999-N-0053-0004 FDA Medical Devices; Reclassification of 38 Preamendments FDA-1999-N-0053 FDA Notice NFR-Notice of Final Rule 2001-11-16T05:00:00Z 2001 11     2008-04-25T00:00:45Z   0 0 09000064804a6196
FDA-1999-N-0083-0001 FDA Assessment of Preclinical Reproductive Toxicity Data FDA-1999-N-0083 FDA Notice NAD-Notice of Availability of Data 2001-11-15T05:00:00Z 2001 11 2001-11-15T05:00:00Z 2002-03-14T04:59:59Z 2008-04-25T00:00:59Z   0 0 09000064804a6982
EPA-HQ-OAR-2002-0003-0084 EPA Boutique Fuels -- White Paper ("Study of Unique Gasoline Fuel Blends ("Boutique Fuels''), Effects on Fuel Supply and Distribution and Potential Improvements'') Legacy Docket ID #: A-2001-20 EPA-HQ-OAR-2002-0003 Notice of Availability for Public Review and Comment of EPA Staff White Paper That Explores a Number of Options for Addressing Boutique Fuels Notice Federal Register Document 2001-11-14T05:00:00Z 2001 11     2021-05-25T01:00:38Z 01-28522 0 0 09000064800bc9fe
FDA-2000-D-0196-0001 FDA Fumonisin Levels in Human Foods and Animal Feed FDA-2000-D-0196 Guidance for Industry: Fumonisin Levels in Human Foods and Animal Feeds; Availability Notice Notice of Availability 2001-11-14T05:00:00Z 2001 11 2001-11-09T05:00:00Z 2002-11-10T04:59:59Z 2018-10-10T18:41:38Z   0 0 09000064804d4563
FDA-2001-D-0137-0002 FDA Evalution of the effects of Orally Inhaled and Intranasal FDA-2001-D-0137 FDA Notice NAD-Notice of Availability of Data 2001-11-06T05:00:00Z 2001 11 2001-11-06T05:00:00Z 2002-02-05T04:59:59Z 2008-04-25T02:25:55Z   0 0 09000064804ddb03
FDA-2001-D-0137-0007 FDA Evalution of the effects of Orally Inhaled and Intranasal FDA-2001-D-0137 FDA Notice NAD-Notice of Availability of Data 2001-11-06T05:00:00Z 2001 11 2001-11-06T05:00:00Z 2002-02-05T04:59:59Z 2008-04-25T02:25:55Z   0 0 09000064804ddb0b
FDA-2001-N-0176-0001 FDA Inhalational Anthrax (Post-Exposure) Doxycycline/PenicillinG FDA-2001-N-0176 FDA Notice N-Notice 2001-11-06T05:00:00Z 2001 11     2008-04-25T02:27:33Z   0 0 09000064804e1102
FDA-2001-N-0176-0002 FDA Inhalational Anthrax (Post-Exposure) Doxycycline/PenicillinG FDA-2001-N-0176 FDA Notice N-Notice 2001-11-06T05:00:00Z 2001 11     2008-04-25T02:27:34Z   0 0 09000064804e133a
FDA-2001-D-0137-0001 FDA Evalution of the effects of Orally Inhaled and Intranasal FDA-2001-D-0137 FDA Notice NAD-Notice of Availability of Data 2001-11-06T05:00:00Z 2001 11 2001-11-06T05:00:00Z 2002-02-05T04:59:59Z 2008-04-25T02:25:55Z   0 0 09000064804ddaef
FDA-2001-N-0074-0002 FDA Withdrawal of 51 NDAs and 25 ANDAs FDA-2001-N-0074 Schering Corp. et al.; Withdrawal of Approval of 51 New Drug Applications and 25 Abbreviated New Drug Applications; Correction Notice Correction 2001-11-06T05:00:00Z 2001 11     2025-01-29T14:22:16Z 01-27520 0 0 09000064804b831d
FDA-2001-D-0137-0006 FDA Evalution of the effects of Orally Inhaled and Intranasal FDA-2001-D-0137 FDA Notice NAD-Notice of Availability of Data 2001-11-06T05:00:00Z 2001 11 2001-11-06T05:00:00Z 2002-02-05T04:59:59Z 2008-04-25T02:25:55Z   0 0 09000064804ddb0a
FDA-2001-D-0137-0009 FDA Evalution of the effects of Orally Inhaled and Intranasal FDA-2001-D-0137 FDA Notice NAD-Notice of Availability of Data 2001-11-06T05:00:00Z 2001 11 2001-11-06T05:00:00Z 2002-02-05T04:59:59Z 2008-04-25T02:25:55Z   0 0 09000064804ddb0d
FDA-2001-D-0137-0008 FDA Evalution of the effects of Orally Inhaled and Intranasal FDA-2001-D-0137 FDA Notice NAD-Notice of Availability of Data 2001-11-06T05:00:00Z 2001 11 2001-11-06T05:00:00Z 2002-02-05T04:59:59Z 2008-04-25T02:25:55Z   0 0 09000064804ddb0c
FDA-2001-N-0074-0003 FDA Withdrawal of 51 NDAs and 25 ANDAs FDA-2001-N-0074 Schering Corp. et al.; Withdrawal of Approval of 51 New Drug Applications and 25 Abbreviated New Drug Applications; Correction Notice Correction 2001-11-06T05:00:00Z 2001 11     2025-01-29T14:37:32Z 01-27520 0 0 09000064804b831e
FDA-2001-D-0137-0003 FDA Evalution of the effects of Orally Inhaled and Intranasal FDA-2001-D-0137 FDA Notice NAD-Notice of Availability of Data 2001-11-06T05:00:00Z 2001 11 2001-11-06T05:00:00Z 2002-02-05T04:59:59Z 2008-04-25T02:25:55Z   0 0 09000064804ddb05
FDA-2001-D-0137-0005 FDA Evalution of the effects of Orally Inhaled and Intranasal FDA-2001-D-0137 FDA Notice NAD-Notice of Availability of Data 2001-11-06T05:00:00Z 2001 11 2001-11-06T05:00:00Z 2002-02-05T04:59:59Z 2008-04-25T02:25:55Z   0 0 09000064804ddb09
FDA-2001-D-0137-0004 FDA Evalution of the effects of Orally Inhaled and Intranasal FDA-2001-D-0137 FDA Notice NAD-Notice of Availability of Data 2001-11-06T05:00:00Z 2001 11 2001-11-06T05:00:00Z 2002-02-05T04:59:59Z 2008-04-25T02:25:55Z   0 0 09000064804ddb08
FDA-2001-D-0219-0001 FDA Establishment & Operation of Clinical Trial Monitoring Comm FDA-2001-D-0219 Draft FDA Guidance on the Estabtishment and Operation of Clinical Trial Data Monitoring Committees; Public Meeting Notice NM-Notice of Meeting 2001-11-05T05:00:00Z 2001 11     2010-05-10T16:33:19Z   0 0 09000064804e4d7b
FDA-2001-N-0016-0001 FDA Veterinary adverse drug reaction, lack of effect, product FDA-2001-N-0016 Agency Information Collection Activities; Submission for OMB Review; Comment Request; Veterinary Adverse Drug Reaction, Lack of Effectiveness, Product Defect Report Notice 30 Day Proposed Information Collection 2001-11-05T05:00:00Z 2001 11 2001-11-05T05:00:00Z 2001-12-06T04:59:59Z 2024-12-17T02:00:53Z 01-27641 0 0 09000064804b4ea8
FDA-2001-N-0171-0001 FDA Medical Devices: Third-Party review under FDAMA;Agency Infor FDA-2001-N-0171 Agency Information Collection Activities; Announcement of OMB Approval; Third-Party Review Under FDAMA Notice Notice of Approval 2001-11-05T05:00:00Z 2001 11     2024-12-16T17:04:30Z 01-27642 0 0 09000064804e0921
FDA-2000-D-0027-0001 FDA Patulin in Apple Juice,Apple Juice Concentrates,Juice Produc FDA-2000-D-0027 FDA Notice NAD-Notice of Availability of Data 2001-11-05T05:00:00Z 2001 11     2008-04-25T01:01:00Z   0 0 09000064804aeaf2
EPA-HQ-OECA-2005-0006-0003 EPA Clean Water Act Class II: Proposed Administrative Settlement, Penalty Assessment and Opportunity to Comment Regarding Standard Steel, a Division of Freedom Forge Corporation EPA-HQ-OECA-2005-0006 Clean Water Act Class II: Proposed Administrative Settlement, Penalty Assessment and Opportunity To Comment Regarding Standard Steel, a Division of Freedom Forge Corporation; Extension of Comment Period [III-A-003] Notice Federal Register Document 2001-10-30T05:00:00Z 2001 10 2001-10-30T05:00:00Z 2001-11-10T04:59:59Z 2010-07-15T19:13:40Z 54770 0 0 09000064800b88c8
FDA-1998-N-0050-0002 FDA Comprehensive List of Current Guidance Documents at FDA FDA-1998-N-0050 Annual Comprehensive List of Guidance Documents at the Food and Drug Administration Notice General Notice 2001-10-29T05:00:00Z 2001 10 2001-10-24T04:00:00Z   2015-04-11T02:07:31Z   0 0 090000648056e813
FDA-2001-N-0174-0001 FDA Electronic Interchange Standard for Digital ECG; Public Meet FDA-2001-N-0174 Electronic Interchange Standard for Digital ECG and Similar Data; Public Meeting Notice Meeting 2001-10-29T05:00:00Z 2001 10     2025-02-06T02:00:57Z 01-26821 0 0 09000064804e0d65
FDA-2001-N-0201-0001 FDA Food Labeling; Notification Procedures on Dietary Supplement FDA-2001-N-0201 Agency Information Collection Activities; Proposed Collection; Comment Request; Food Labeling; Notification Procedures for Statements on Dietary Supplements Notice 60 Day Proposed Information Collection 2001-10-29T05:00:00Z 2001 10     2025-02-04T17:06:58Z 01-26885 0 0 09000064804e35f6
FDA-1999-F-0120-0003 FDA Listed Gum or Wood Rosin Derivatives FDA-1999-F-0120 Food Additives Permitted for Direct Addition to Food for Human Consumption; Change in Specifications for Gum or Wood Rosin Derivatives in Chewing Gum Base; Correction Notice Correction 2001-10-29T00:00:00Z 2001 10     2025-05-02T18:20:56Z 01-26708 0 0 09000064804ae961
FDA-2001-N-0199-0001 FDA Premarket Notification 510(k) Submissions FDA-2001-N-0199 Agency Information Collection Activities; Announcement of OMB Approval; Premarket Notification 510(k) Submissions Notice Notice of Approval 2001-10-26T04:00:00Z 2001 10     2024-12-10T16:05:25Z 01-26573 0 0 09000064804e3357
FDA-2001-D-0094-0002 FDA Channels of trade policy for Commodities with Vinclozolin FDA-2001-D-0094 FDA Notice N-Notice 2001-10-23T04:00:00Z 2001 10 2001-10-23T04:00:00Z 2001-11-24T04:59:59Z 2008-04-25T02:23:58Z   0 0 09000064804b90d5
FDA-2001-N-0104-0001 FDA Fast Track Drug Development Programs: Designation, Development, and Application Review FDA-2001-N-0104 Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry: Fast Track Drug Development Programs-Designation, Development, and Application Review Notice 60 Day Proposed Information Collection 2001-10-23T04:00:00Z 2001 10 2001-10-23T04:00:00Z 2001-12-25T04:59:59Z 2025-02-03T20:03:20Z 01-26575 0 0 09000064804bae60
FDA-1980-N-0074-0074 FDA Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 FDA Notice N-Notice 2001-10-22T04:00:00Z 2001 10 2001-10-22T04:00:00Z 2002-01-15T04:59:59Z 2008-05-30T22:53:09Z   0 0 09000064805bb4da
FDA-2001-N-0170-0001 FDA Medical Device Labeling Regulations FDA-2001-N-0170 Agency Information Collection Activities; Submission for OMB Review; Comment Request; Medical Device Labeling Regulations Notice 30 Day Proposed Information Collection 2001-10-19T04:00:00Z 2001 10 2001-10-16T04:00:00Z 2001-11-16T04:59:59Z 2024-12-19T19:57:40Z 01-25943 0 0 09000064804e07d0
FDA-2001-N-0566-0001 FDA New Animal Drugs for Investigational;Agency Information Coll FDA-2001-N-0566 Agency Information Collection Activities; Proposed Collection; Comment Request; New Animal Drugs for Investigational Use Notice 60 Day Proposed Information Collection 2001-10-19T04:00:00Z 2001 10 2001-10-16T04:00:00Z 2001-12-18T04:59:59Z 2025-02-03T18:49:59Z 01-25918 0 0 090000648050b0cb
EPA-HQ-RCRA-2001-0008-0011 EPA EPA-HQ-RCRA-2001-0008 Notice of Availability of the Draft Guidance on Demonstrating Compliance With the Land Disposal Restrictions Alternative Soil Treatment Standards, and the Draft Interpretative Memorandum on the Stabilization of Organic-Bearing Hazardous Wastes [F-2001-DRG2-FFFFF] Notice Federal Register Document 2001-10-18T04:00:00Z 2001 10 2001-10-18T04:00:00Z 2001-12-04T04:59:59Z 2008-01-08T21:09:42Z 52918 0 0 09000064800def81
EPA-HQ-RCRA-2001-0050-0084 EPA EPA-HQ-RCRA-2001-0050 National Recommended Water Quality Criteria; Republication; Compilation of Recommended Water Quality Criteria and Notice of Process for New and Revised Criteria Notice Federal Register Document 2001-10-15T04:00:00Z 2001 10     2008-01-08T21:11:36Z 68354 0 0 09000064800e35e2
EPA-HQ-OECA-2005-0005-0003 EPA Clean Water Act Class II: Proposed Administrative Settlement, Penalty Assessment and Opportunity to Comment Regarding WorldCom, Inc. EPA-HQ-OECA-2005-0005 Corrected Federal Register Notice for original Federal Register which is document number OECA-2005-0005-0002 [III-A-002] Notice Federal Register Document 2001-10-12T04:00:00Z 2001 10 2001-10-12T04:00:00Z 2001-11-14T04:59:59Z 2010-07-15T19:13:40Z 52135 0 0 09000064800b8854
EPA-HQ-RCRA-2001-0007-0006 EPA EPA-HQ-RCRA-2001-0007 Notice of the Availability of the Draft Guidance in Demonstrating Compliance with the Land Disposal Restrictions Alternative Soil Treatment Standards, and the Draft Interpretative Memorandum on the Stabilization of Organic-Bearing Hazardous Wastes [F-2001-DRG1-FFFFF] Notice Federal Register Document 2001-10-12T04:00:00Z 2001 10 2001-10-12T04:00:00Z 2001-12-04T04:59:59Z 2022-04-21T01:00:44Z 52918 0 0 09000064800def23
FDA-1998-D-0037-0001 FDA Format for Geriatric Labeling FDA-1998-D-0037 FDA Notice NAD-Notice of Availability of Data 2001-10-12T04:00:00Z 2001 10 2001-10-12T04:00:00Z 2002-10-06T03:59:59Z 2008-05-16T21:18:13Z   0 0 0900006480565bc6
FDA-2000-D-0100-0002 FDA Clinical Data In Marketing Applications FDA-2000-D-0100 FDA Notice NAD-Notice of Availability of Data 2001-10-12T04:00:00Z 2001 10 2001-10-12T04:00:00Z 2002-10-06T03:59:59Z 2008-04-25T01:47:25Z   0 0 09000064804c217b
FDA-2000-P-0102-0004 FDA Health Claim: Vegetable Oil Sterol Esters & Coronary Heart Disease CLOSED 05/26/2020 FDA-2000-P-0102 FDA Notice NEC-Notice of Extension 2001-10-12T04:00:00Z 2001 10 2001-10-12T04:00:00Z 2001-11-20T04:59:59Z 2008-04-25T01:47:38Z   0 0 09000064804c22da
FDA-2000-P-0133-0004 FDA Health Claim: Plant Stanol Esters and Heart Disease CLOSED 05/26/2020 FDA-2000-P-0133 FDA Notice NEC-Notice of Extension 2001-10-12T04:00:00Z 2001 10 2001-10-12T04:00:00Z 2001-11-20T04:59:59Z 2008-04-25T01:16:05Z   0 0 09000064804cfd51
FDA-1998-D-0037-0002 FDA Format for Geriatric Labeling FDA-1998-D-0037 FDA Notice NAD-Notice of Availability of Data 2001-10-12T04:00:00Z 2001 10 2001-10-12T04:00:00Z 2002-10-06T03:59:59Z 2008-05-16T21:18:13Z   0 0 0900006480565c35
FDA-2001-N-0068-0001 FDA GLP Regulations for Nonclinical Laboratory Studies FDA-2001-N-0068 Agency Information Collection Activities; Announcement of OMB Approval; Good Laboratory Practices (GLP) Regulations for Nonclinical Laboratory Studies Notice Notice of Approval 2001-10-12T04:00:00Z 2001 10     2025-02-11T16:56:25Z 01-25659 0 0 09000064804b81dc
FDA-2001-N-0226-0002 FDA Reports of Corrections and Removals:Agency Information Colle FDA-2001-N-0226 Agency Information Collection Activities; Submission for OMB Review; Comment Request; Reports of Corrections and Removals Notice 30 Day Proposed Information Collection 2001-10-12T04:00:00Z 2001 10 2001-10-12T04:00:00Z 2001-11-14T04:59:59Z 2025-01-15T20:59:09Z 01-25660 0 0 09000064804e57a8
FDA-2001-N-0072-0001 FDA CGMP Regulations for Type A Medicated Articles FDA-2001-N-0072 Agency Information Collection Activities; Announcement of OMB Approval; Current Good Manufacturing Practice Regulations for Type A Medicated Articles Notice Notice of Approval 2001-10-12T04:00:00Z 2001 10     2024-11-26T02:00:30Z 01-25658 0 0 09000064804b82d8
FDA-2001-N-0105-0001 FDA Third-Party Submissions review/quality system inspections FDA-2001-N-0105 Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Devices; Third-Party Premarket Submission Review and Quality System Inspections Under United States/European Community Mutual Recognition Agreement Notice 60 Day Proposed Information Collection 2001-10-12T04:00:00Z 2001 10 2001-10-05T04:00:00Z 2001-12-05T04:59:59Z 2025-01-31T16:15:35Z 01-24998 0 0 09000064804bafb0
EPA-HQ-RCRA-2002-0004-0001 EPA EPA-HQ-RCRA-2002-0004 Notice of the Availability; The Office of Solid Waste Announces the Availability of a New Guidance Document; Risk Burn Guidance for Hazardous Waste Combustion Facitities (Supporting Materials are in the File for the Draft Guidance, (F-1998-GCEA-FFFFF) Notice Federal Register Document 2001-10-11T04:00:00Z 2001 10     2008-01-08T21:17:57Z 51953 0 0 09000064800dfa6e
EPA-HQ-RCRA-2001-0028-0001 EPA EPA-HQ-RCRA-2001-0028 Agency Information Collection Activities Up for Renewal: Comment Request; State Program Adequacy Determination Notice Federal Register Document 2001-10-11T04:00:00Z 2001 10 2001-10-11T04:00:00Z 2001-12-11T04:59:59Z 2008-01-08T21:12:21Z 51949 0 0 09000064800e1a11
FDA-2000-D-0068-0001 FDA Electronic Signatures: Glossary of Terms FDA-2000-D-0068 FDA Notice NCR-Notice of Correction 2001-10-11T04:00:00Z 2001 10     2008-04-25T01:13:24Z   0 0 09000064804afe17
EPA-HQ-OECA-2005-0006-0002 EPA Clean Water Act Class II: Proposed Administrative Settlement, Penalty Assessment and Opportunity to Comment Regarding Standard Steel, a Division of Freedom Forge Corporation EPA-HQ-OECA-2005-0006 Corrected Federal Register Notice for original Federal Register which is document number OECA-2005-0006-0001 [III-A-002] Notice Federal Register Document 2001-10-10T04:00:00Z 2001 10 2001-10-10T04:00:00Z 2001-10-30T04:59:59Z 2010-07-15T19:13:40Z 51667 0 0 09000064800b88b9
FDA-2001-N-0202-0002 FDA Workshop on Preclinical Testing for Endovascular Grafts FDA-2001-N-0202 Workshop on Preclinical Testing for Endovascular Grafts Notice NM-Notice of Meeting 2001-10-10T04:00:00Z 2001 10     2009-01-07T16:52:55Z   0 0 09000064804e3787
FDA-2001-N-0202-0001 FDA Workshop on Preclinical Testing for Endovascular Grafts FDA-2001-N-0202 Workshop on Preclinical Testing for Endovascular Grafts Notice NM-Notice of Meeting 2001-10-10T04:00:00Z 2001 10     2009-01-07T16:51:36Z 01–16471 0 0 09000064804e373f
FDA-2001-N-0567-0001 FDA Substances Prohibited from use in animal food/Feed Ruminant FDA-2001-N-0567 FDA Notice NH-Notice of Hearing 2001-10-10T04:00:00Z 2001 10     2008-04-25T02:39:30Z   0 0 090000648050b0de
FDA-2001-N-0047-0002 FDA Progress on implementing for the common technical document FDA-2001-N-0047 Preparation for ICH Meetings in Brussels, Belgium, Including Progress on Implementing of the Common Technical Document; Public Meeting; Cancellation Notice General Notice 2001-10-02T04:00:00Z 2001 10     2025-01-30T19:01:03Z 01-24528 0 0 09000064804b78ae
EPA-HQ-RCRA-2003-0018-0001 EPA EPA-HQ-RCRA-2003-0018 Agency Information Collection Activities: Submission for OMB Review; Comment Request; Criteria for Classification of Solid Waste Disposal Facilities and Practices, Recordkeeping and Reporting Requirements; 40 CFR Part 257, Subpart B; Notice Notice Federal Register Document 2001-10-01T04:00:00Z 2001 10 2001-10-01T04:00:00Z 2002-11-01T04:59:59Z 2008-01-08T21:13:35Z 61621 0 0 09000064800e3822
FDA-2001-P-0005-0001 FDA Determination that Disulfiram was withdrawn for reasons othe FDA-2001-P-0005 Notice of Determination Notice N-Notice 2001-10-01T04:00:00Z 2001 10     2024-08-28T13:26:37Z   0 0 09000064804b4014
FDA-2001-N-0173-0001 FDA Rapid Response Surveys;Agency Information Collection FDA-2001-N-0173 Agency Information Collection Activities; Proposed Collection; Comment Request; Rapid Response Surveys Notice 60 Day Proposed Information Collection 2001-10-01T04:00:00Z 2001 10 2001-09-27T04:00:00Z 2001-11-27T04:59:59Z 2025-01-30T21:09:38Z 01-24163 0 0 09000064804e0bdd
FDA-1998-D-0037-0003 FDA Format for Geriatric Labeling FDA-1998-D-0037 Content and Format for Geriatric Labeling Notice Guidance 2001-10-01T04:00:00Z 2001 10 2001-10-01T04:00:00Z   2021-10-01T04:02:28Z   0 0 0900006480565c32
EPA-HQ-OECA-2005-0006-0001 EPA Clean Water Act Class II: Proposed Administrative Settlement, Penalty Assessment and Opportunity to Comment Regarding Standard Steel, a Division of Freedom Forge Corporation EPA-HQ-OECA-2005-0006 Clean Water Act Class II: Proposed Administrative Settlement, Penalty Assessment and Opportunity to Comment Regarding Standard Steel, a Division of Freedom Forge Corporation [III-A-001] Notice Federal Register Document 2001-09-27T04:00:00Z 2001 9 2001-09-27T04:00:00Z 2001-10-30T04:59:59Z 2010-07-15T19:13:40Z 49379 0 0 09000064800b88a4
FDA-2000-D-0002-0003 FDA Q7A ICH Good Manufacturing Practice Guide for Active Pharmaceuticals FDA-2000-D-0002 FDA Notice NAD-Notice of Availability of Data 2001-09-26T04:00:00Z 2001 9     2008-04-25T01:13:52Z   0 0 09000064804ae5c1
FDA-2001-N-0172-0001 FDA Prescription Drug Product Labeling; Medication Guide Require FDA-2001-N-0172 FDA Notice N-Notice 2001-09-26T04:00:00Z 2001 9 2001-09-26T04:00:00Z 2001-11-27T04:59:59Z 2008-04-25T02:27:22Z   0 0 09000064804e0a96
FDA-2001-D-0164-0001 FDA Guidance ICH Q1D Bracketing and Matrixing Designs for Stabil FDA-2001-D-0164 FDA Notice NAD-Notice of Availability of Data 2001-09-26T04:00:00Z 2001 9 2001-09-26T04:00:00Z 2001-11-27T04:59:59Z 2008-04-25T02:27:39Z   0 0 09000064804dff39
FDA-2001-N-0175-0001 FDA Transportation Safety & Potentially Sedating or Impairing FDA-2001-N-0175 Meeting on 11/14-15/01 Notice NM-Notice of Meeting 2001-09-24T04:00:00Z 2001 9 2001-09-24T04:00:00Z 2001-12-18T04:59:59Z 2008-04-25T02:27:52Z   0 0 09000064804e0ed7
FDA-2000-D-0031-0001 FDA Electronic Records; Electronic Signatures, Validation FDA-2000-D-0031 FDA Notice NAD-Notice of Availability of Data 2001-09-24T04:00:00Z 2001 9 2001-09-24T04:00:00Z 2001-12-25T04:59:59Z 2008-04-25T01:12:34Z   0 0 09000064804aeb8d
FDA-2001-E-0151-0001 FDA Patent Extension for Trileptal, No. 4,559,174 FDA-2001-E-0151 Determination of Regulatory Review Period for Purposes of Patent Extension; Trileptal Notice General Notice 2001-09-24T04:00:00Z 2001 9 2001-09-24T04:00:00Z 2001-11-24T04:59:59Z 2025-09-15T16:10:58Z   0 0 09000064804ddd1d
FDA-2000-E-0239-0001 FDA Patent Extension Synercid #4,668,669 FDA-2000-E-0239 Determination of Regulatory Review Period for Purposes of Patent Extension; Synercid Notice General Notice 2001-09-21T04:00:00Z 2001 9 2001-09-21T04:00:00Z 2002-03-21T04:59:59Z 2025-07-09T16:09:54Z   0 0 09000064804d59f6
FDA-2001-E-0210-0001 FDA Kaletra, Patent Extension Application No.5,886,036 FDA-2001-E-0210 Determination of Regulatory Review Period for Purposes of Patent Extension; Kaletra Notice General Notice 2001-09-21T04:00:00Z 2001 9 2001-09-21T04:00:00Z 2002-03-21T04:59:59Z 2025-10-01T18:13:42Z   0 0 09000064804e41c2
FDA-2001-F-0180-0001 FDA use of mixture of peroxyacetic acid,octanoic acid,acetic FDA-2001-F-0180 Secondary Direct Food Additives Permitted in Food for Human Consumption Notice Notice of Final Rule 2001-09-21T04:00:00Z 2001 9 2001-09-21T04:00:00Z 2001-10-20T03:59:59Z 2025-11-06T20:46:42Z   0 0 09000064804e1878
FDA-2001-E-0234-0001 FDA Rescula, Patent Extension Application No. 5,221,763 FDA-2001-E-0234 Determination of Regulatory Review Period for Purposes of Patent Extension; Rescula Notice General Notice 2001-09-21T04:00:00Z 2001 9 2001-09-21T04:00:00Z 2002-03-21T04:59:59Z 2025-10-10T22:02:07Z   0 0 09000064804e6296
EPA-HQ-ORD-2004-0012-0001 EPA EPA-HQ-ORD-2004-0012 Trichloroethylene Health Risk Assessment Notice Federal Register Document 2001-09-19T04:00:00Z 2001 9     2025-06-27T02:26:44Z 58257 0 0 09000064800c49bb
FDA-1996-P-0025-0001 FDA Reduce the Precense of Salmonella Enteritidis in Shell Eggs - CLOSED FDA-1996-P-0025 FDA Notice Notice of Availability 2001-09-18T04:00:00Z 2001 9 2001-09-18T04:00:00Z 2002-09-08T03:59:59Z 2016-05-31T16:17:22Z   0 0 09000064804faaa3
FDA-1998-N-0087-0001 FDA Labeling of Shell Eggs;Shell Eggs: Refrigeration of Shell FDA-1998-N-0087 FDA Notice NAD-Notice of Availability of Data 2001-09-18T04:00:00Z 2001 9 2001-09-18T04:00:00Z 2002-09-08T03:59:59Z 2008-05-16T21:37:51Z   0 0 0900006480585263
FDA-1994-P-0050-0002 FDA Amend Reference Amount for Baking Soda to read 1/8 tsp FDA-1994-P-0050 FDA Notice NAD-Notice of Availability of Data 2001-09-18T04:00:00Z 2001 9 2001-09-18T04:00:00Z 2002-09-08T03:59:59Z 2008-05-16T23:21:35Z   0 0 09000064804ffa38
FDA-1997-P-0017-0002 FDA Require that warning labels about risks of salmonella enteri FDA-1997-P-0017 Notice of Availability of Data re Small Entity Compliance Guide: “Food Labeling: Safe Handling Statements, Labeling of Shell Eggs; Refrigeration of Shell Eggs Held for Retail Distribution;” Availability Notice Notice of Data Availability 2001-09-18T04:00:00Z 2001 9 2001-09-18T04:00:00Z 2002-09-08T03:59:59Z 2015-05-12T15:29:10Z   0 0 09000064805c9fc0
FDA-2001-N-0047-0001 FDA Progress on implementing for the common technical document FDA-2001-N-0047 Preparation for ICH Meetings in Brussels, Belgium, Including Progress on Implementing of the Common Technical Document; Public Meeting Notice Meeting 2001-09-12T04:00:00Z 2001 9     2025-01-30T17:36:45Z 01-22471 0 0 09000064804b78a3
FDA-2001-N-0133-0002 FDA Exemption From Premarket Notification Requirements; Class 1 FDA-2001-N-0133 Medical Devices; Exemption From Premarket Notification Requirements; Class I Devices Notice Correction 2001-09-10T04:00:00Z 2001 9     2025-02-11T15:27:21Z 01-22577 0 0 09000064804dda85

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);